Using ovalbumin as a second tumour antigen model (Fig. 1q), we recapitulated the different in vivo expansion dynamics of adoptively transferred ovalbumin-specific OT-II TCRtg CD4+ T cells and OT-I TCRtg CD8+ T cells (Extended Data Fig. 3f,g). The gene discussed is CD8A; the disease is neoplasm.